• Cat-intel
  • MedIntelliX
  • Resources
  • About Us
  • Request Free Sample ×

    Kindly complete the form below to receive a free sample of this Report

    Leading companies partner with us for data-driven Insights

    clients tt-cursor
    Hero Background

    Tourette Syndrome Market

    ID: MRFR/HC/26239-HCR
    100 Pages
    Rahul Gotadki
    October 2025

    Tourette Syndrome Market Research Report By End-User (Individuals with Tourette Syndrome, Healthcare Professionals, Educational Institutions, Non-Profit Organizations, Research Institutions), By Type of Treatment (Medications, Behavioral Therapy, Neuromodulation Therapies (e.g., DBS, TMS), Complementary and Alternative Medicine (e.g., acupuncture, herbal remedies), Other Therapies), By Severity of Symptoms (Mild, Moderate, Severe), By Diagnostic Tools (Clinical Examination, Diagnostic Interviews, Observational Scales (e.g., Yale Global Tic S...

    Share:
    Download PDF ×

    We do not share your information with anyone. However, we may send you emails based on your report interest from time to time. You may contact us at any time to opt-out.

    Tourette Syndrome Market Infographic
    Purchase Options

    Tourette Syndrome Market Summary

    The global Tourette Syndrome market is projected to grow from 1.29 USD billion in 2024 to 2.36 USD billion by 2035.

    Key Market Trends & Highlights

    Tourette Syndrome Key Trends and Highlights

    • The market is expected to experience a compound annual growth rate of 5.64 percent from 2025 to 2035.
    • By 2035, the market valuation is anticipated to reach 2.36 USD billion, indicating robust growth.
    • in 2024, the market is valued at 1.29 USD billion, reflecting the increasing awareness and diagnosis of Tourette Syndrome.
    • Growing adoption of innovative treatment options due to rising prevalence of Tourette Syndrome is a major market driver.

    Market Size & Forecast

    2024 Market Size 1.29 (USD Billion)
    2035 Market Size 2.36 (USD Billion)
    CAGR (2025-2035) 5.64%

    Major Players

    Neurelis, Inc., Xenon Pharmaceuticals, Inc., Arbor Pharmaceuticals, LLC, Cerevel Therapeutics, Neurocrine Biosciences, Inc., Lundbeck, UCB, Abide Therapeutics, Biogen, Sunovion Pharmaceuticals, Catalyst Pharmaceuticals, Bausch Health Companies, Boehringer Ingelheim, Xeris Pharmaceuticals, Teva Pharmaceutical Industries, Eli Lilly and Company, Novartis, Shire (now part of Takeda), Acorda Therapeutics

    Tourette Syndrome Market Trends

    The Tourette Syndrome market has gained significant attention due to its increasing prevalence and the rising demand for effective treatments. Key market drivers include growing awareness about the condition, advances in diagnostic techniques, and the development of innovative therapeutic approaches.

    Opportunities for market growth lie in expanding access to healthcare services, particularly in underserved regions, and the exploration of novel therapies, such as gene therapy and deep brain stimulation. 

    Recent trends in the market include the integration of technology in diagnosis and treatment, the personalization of treatment plans, and the increasing focus on co-occurring conditions associated with Tourette Syndrome.

    These factors contribute to the expanding market landscape and offer opportunities for stakeholders to address the evolving needs of patients and their families.

    The increasing recognition of Tourette Syndrome as a complex neurodevelopmental disorder is likely to drive advancements in therapeutic interventions and support systems for affected individuals.

    National Institute of Neurological Disorders and Stroke (NINDS)

    Tourette Syndrome Market Drivers

    Market Growth Projections

    The Global Tourette Syndrome Market Industry is projected to experience substantial growth over the coming years. With a market size of 1.29 USD Billion in 2024, the industry is anticipated to expand significantly, reaching 2.36 USD Billion by 2035. This growth is underpinned by a compound annual growth rate of 5.64% from 2025 to 2035. Various factors, including increasing awareness, advancements in treatment options, and supportive government policies, are likely to contribute to this upward trajectory. The market's expansion reflects a growing recognition of the need for effective management strategies for individuals affected by Tourette Syndrome.

    Supportive Government Policies

    Supportive government policies play a crucial role in shaping the Global Tourette Syndrome Market Industry. Governments are increasingly recognizing the need for comprehensive care and support for individuals with Tourette Syndrome. Initiatives aimed at funding research, improving access to healthcare services, and promoting awareness are likely to bolster the market. These policies may facilitate the development of new therapies and enhance the overall quality of care for patients. As a result, the market is expected to grow at a compound annual growth rate of 5.64% from 2025 to 2035, reflecting the positive impact of governmental support.

    Growing Research and Development

    The Global Tourette Syndrome Market Industry is benefiting from a surge in research and development activities focused on understanding the underlying mechanisms of Tourette Syndrome. Increased funding for scientific studies and clinical trials is likely to yield new insights into the disorder, potentially leading to the discovery of novel treatment approaches. This emphasis on research may also foster collaboration between academic institutions and pharmaceutical companies, further driving innovation in the field. As a result, the market is poised for growth, with an anticipated increase in investment in R&D initiatives.

    Advancements in Treatment Options

    The Global Tourette Syndrome Market Industry is witnessing significant advancements in treatment options, which may enhance patient outcomes. Innovative therapies, including behavioral interventions and pharmacological treatments, are being developed and refined. For instance, the introduction of new medications targeting specific symptoms of Tourette Syndrome could provide patients with more effective management strategies. As these treatment options become more widely available, they are likely to attract attention from healthcare providers and patients alike. This trend is expected to contribute to the market's growth, with projections indicating a market size of 2.36 USD Billion by 2035.

    Increasing Awareness and Diagnosis

    The Global Tourette Syndrome Market Industry is experiencing a notable increase in awareness and diagnosis of Tourette Syndrome. This trend is largely attributed to educational initiatives and advocacy efforts aimed at reducing stigma and promoting understanding of the disorder. As healthcare professionals become more informed about the symptoms and characteristics of Tourette Syndrome, the rate of diagnosis is likely to rise. This increased recognition may lead to a higher demand for treatment options, contributing to the market's growth. In 2024, the market is projected to reach 1.29 USD Billion, indicating a growing recognition of the disorder.

    Rising Prevalence of Tourette Syndrome

    The rising prevalence of Tourette Syndrome is a significant driver of the Global Tourette Syndrome Market Industry. Epidemiological studies suggest that the disorder affects a notable percentage of the population, leading to increased demand for healthcare services and interventions. As awareness of Tourette Syndrome grows, more individuals are likely to seek diagnosis and treatment, further contributing to market expansion. This trend is expected to be reflected in the market's growth trajectory, with projections indicating a market size of 2.36 USD Billion by 2035.

    Market Segment Insights

    Tourette Syndrome End-User Insights

    The Tourette Syndrome Market is segmented by End-User into Individuals with Tourette Syndrome, Healthcare Professionals, Educational Institutions, Non-Profit Organizations and Research Institutions. The market segment of Individuals with Tourette Syndrome contributed the greatest share to the market revenue, which was approximately 45% in 2023. 

    The Healthcare Professionals’ market segment is expected to grow greatly over the years of the forecast, due to the increasing prevalence of the Tourette Syndrome and the growing need for special care.

    The market of Educational Institutions is also likely to contribute to the growth, as there is increasing awareness of the disease and the need for schools to provide support and education. 

    The role of Non-Profit Organizations is vital, as they provide important support for Individuals with Tourette Syndrome and their relatives; as a result, their market share is likely to increase as the demand for their services grows. The market of Research Institutions, in turn, is going to grow as their role in discovering new treatments and therapies for Tourette Syndrome is expanding.

    Overall, the Tourette Syndrome Market is going to amount to 1.23 billion USD in 2024, growing at a CAGR of 9.1% during the forecast period.

    Tourette Syndrome Type of Treatment Insights

    The Tourette Syndrome Market Segmentation by Type of Treatment includes Medications, Behavioural Therapy, Neuromodulation Devices Therapies, Complementary and Alternative Medicine, and Other Therapies.

    Medications held the largest market share in 2023, owing to the widespread use of drugs like alpha-2 agonists, dopamine antagonists, and antipsychotics. Behavioural Therapy is projected to witness the highest CAGR during the forecast period, due to its effectiveness in managing tics and improving social functioning.

    Neuromodulation Therapies, such as Deep Brain Stimulation (DBS) and Transcranial Magnetic Stimulation (TMS), offer promising treatment options for severe cases of Tourette Syndrome.

    Complementary and Alternative Medicine, including acupuncture and herbal remedies, are gaining popularity as adjunctive therapies. Other Therapies, such as habit reversal training, support groups, and educational interventions, play a crucial role in managing the condition.

    The Tourette Syndrome Market revenue from Medications segment is expected to reach USD 0.64 billion by 2032, growing at a CAGR of 8.2%.

    Tourette Syndrome Severity of Symptoms Insights

    The severity of symptoms is a key segmentation factor in the Tourette Syndrome Market. The market is divided into three segments based on the severity of symptoms: mild, moderate, and severe.

    The mild segment is expected to account for the largest share of the market in 2023, with a market value of USD 0.61 billion. The moderate segment is expected to follow, with a market value of USD 0.32 billion. 

    The severe segment is expected to account for the smallest share of the market, with a market value of USD 0.14 billion. The market growth for the mild segment is expected to be driven by the increasing prevalence of Tourette Syndrome and the growing awareness of the condition.

    The moderate segment is expected to grow at a steady pace, while the severe segment is expected to experience the slowest growth due to the limited number of treatment options available.

    Tourette Syndrome Diagnostic Tools Insights

    Diagnostic tools play a crucial role in identifying and assessing the severity of Tourette Syndrome. Clinical examination, diagnostic interviews, observational scales and neuroimaging techniques are widely used for diagnosis.

    Clinical examination involves a physical examination and assessment of the patient's medical history and symptoms. Diagnostic interviews involve structured questionnaires and interviews to gather information about the patient's symptoms, family history, and environmental factors. 

    Observational scales, such as the Yale Global Tic Severity Scale, provide standardized methods for quantifying the frequency and severity of tics.

    Neuroimaging techniques, including MRI and EEG, help visualize brain structures and assess brain activity patterns associated with Tourette Syndrome. The increasing prevalence of Tourette Syndrome and the growing awareness of its impact on individuals' lives are driving the demand for diagnostic tools. 

    Advancements in neuroimaging technology, such as the development of functional MRI, are enhancing diagnostic capabilities and providing insights into the underlying mechanisms of Tourette Syndrome. The availability of genetic testing is also contributing to the improved diagnosis and management of the condition.

    Tourette Syndrome Therapeutic Interventions Insights

    Cognitive Behavioral Therapy (CBT), Exposure and Response Prevention Therapy (ERP), Habit Reversal Training (HRT), Mindfulness-Based Interventions (MBIs), and Other Behavioural Interventions are essential therapeutic interventions in the Tourette Syndrome Market.

    These therapies aim to modify maladaptive behaviours and thought patterns associated with Tourette Syndrome. In 2023, the Therapeutic Interventions segment is projected to reach a market value of USD 1.07 billion. 

    CBT is the most widely used intervention, helping individuals identify and challenge negative thoughts and behaviors. ERP involves gradually exposing individuals to anxiety-provoking situations while teaching them coping mechanisms. HRT focuses on replacing unwanted tics with more acceptable behaviours. 

    MBIs enhance self-awareness and emotional regulation. Other Behavioral Interventions include social skills training, parent training, and support groups. The increasing prevalence of Tourette Syndrome and growing awareness of therapeutic interventions drive market growth.

    Get more detailed insights about Tourette Syndrome Market

    Regional Insights

    The Tourette Syndrome Market revenue was valued at 1.07 USD Billion in 2023, and it is projected to reach 2.31 USD Billion by 2032, exhibiting a CAGR of 8.93% during the forecast period.

    Regionally, North America accounted for the largest market share in 2023, followed by Europe, APAC, South America and MEA.

    North America's dominance can be attributed to the high prevalence of Tourette syndrome in the region, as well as the availability of advanced healthcare infrastructure and treatment options.

    Europe is another significant market for Tourette syndrome treatment, driven by the presence of well-established healthcare systems and a large patient population.

    APAC is expected to witness the fastest growth in the Tourette syndrome market during the forecast period, owing to the increasing awareness of the condition and the growing availability of treatment options in the region.

    South America and MEA are expected to contribute a smaller share of the Tourette Syndrome Market, but they are also expected to experience steady growth in the coming years.

    Tourette Syndrome Market Regional Insights

    Source: Primary Research, Secondary Research, Market Research Future Database and Analyst Review

    Key Players and Competitive Insights

    Major players in Tourette Syndrome industry are constantly striving to develop innovative treatments and therapies to address the unmet needs of patients. Leading Tourette Syndrome Market players are investing heavily in research and development to bring new products to market and expand their market share.

    The Tourette Syndrome Market is highly competitive, with several established players and emerging challengers. Key players in this market include Neurelis, Inc., Xenon Pharmaceuticals, Inc., and Arbor Pharmaceuticals, LLC. 

    These companies are focused on developing and commercializing novel therapies for the treatment of Tourette Syndrome. Cerevel Therapeutics is a leading company in the Tourette Syndrome Market industry.

    The company's lead product, inebilizumab, is a monoclonal antibody that targets the CD19 antigen in B cells. Inebilizumab has shown promising results in clinical trials for the treatment of Tourette Syndrome and is expected to be approved by the FDA in 2023. 

    Cerevel Therapeutics is also developing other novel therapies for the treatment of Tourette Syndrome, including a small molecule inhibitor of the sigma-1 receptor.

    Another major player in the Tourette Syndrome Market is Neurocrine Biosciences, Inc. The company's lead product, valbenazine, is a selective vesicular monoamine transporter 2 (VMAT2) inhibitor that is approved for the treatment of Tourette Syndrome in adults and children.

    Valbenazine has shown efficacy in reducing the severity of tics in patients with Tourette Syndrome and is generally well-tolerated. 

    Neurocrine Biosciences is also developing other novel therapies for the treatment of Tourette Syndrome, including a long-acting formulation of valbenazine.

    Key Companies in the Tourette Syndrome Market market include

    Industry Developments

    The Tourette Syndrome Market is anticipated to reach USD 2.31 billion by 2032, expanding at a CAGR of 8.93% from 2024 to 2032. Rising prevalence of Tourette Syndrome, growing awareness about the condition, and advancements in treatment options drive market growth. 

    Key developments include the approval of new therapies, such as Nuplazid and Gocovri, and the increasing adoption of behavioral therapies and deep brain stimulation. Strategic collaborations and acquisitions among market players are also shaping the competitive landscape.

    Future Outlook

    Tourette Syndrome Market Future Outlook

    The Global Tourette Syndrome Market is projected to grow at a 5.64% CAGR from 2025 to 2035, driven by increased awareness, advancements in treatment options, and supportive policies.

    New opportunities lie in:

    • Develop innovative digital therapeutics tailored for Tourette Syndrome management.
    • Expand clinical trial initiatives to explore novel treatment combinations.
    • Leverage telemedicine platforms to enhance patient access to specialists.

    By 2035, the market is expected to demonstrate robust growth, reflecting advancements in treatment and increased patient support.

    Market Segmentation

    Tourette Syndrome End-User Outlook

    • Individuals with Tourette Syndrome
    • Healthcare Professionals
    • Educational Institutions
    • Non-Profit Organizations
    • Research Institutions

    Tourette Syndrome Regional Outlook

    • North America
    • Europe
    • South America
    • Asia Pacific
    • Middle East and Africa

    Tourette Syndrome Diagnostic Tools Outlook

    • Clinical Examination
    • Diagnostic Interviews
    • Observational Scales (e.g., Yale Global Tic Severity Scale)
    • Neuroimaging Techniques (e.g., MRI, EEG)

    Tourette Syndrome Type of Treatment Outlook

    • Medications
    • Behavioral Therapy
    • Neuromodulation Therapies (e.g., DBS, TMS)
    • Complementary and Alternative Medicine (e.g., acupuncture, herbal remedies)
    • Other Therapies

    Tourette Syndrome Severity of Symptoms Outlook

    • Mild
    • Moderate
    • Severe

    Tourette Syndrome Therapeutic Interventions Outlook

    • Cognitive Behavioral Therapy
    • Exposure and Response Prevention Therapy
    • Habit Reversal Training
    • Mindfulness-Based Interventions
    • Other Behavioral Interventions

    Report Scope

    Report Attribute/Metric Details
    Market Size 2024 1.29 (USD Billion)
    Market Size 2035 2.36 (USD Billion)
    Compound Annual Growth Rate (CAGR) 5.64% (2025 - 2035)
    Report Coverage Revenue Forecast, Competitive Landscape, Growth Factors, and Trends
    Base Year 2024
    Market Forecast Period 2025 - 2035
    Historical Data 2019 - 2023
    Market Forecast Units USD Billion
    Key Companies Profiled Lundbeck, UCB, Abide Therapeutics, Biogen, Sunovion Pharmaceuticals, Arbor Pharmaceuticals, Catalyst Pharmaceuticals, Bausch Health Companies, Boehringer Ingelheim, Xeris Pharmaceuticals, Teva Pharmaceutical Industries, Eli Lilly and Company, Novartis, Shire (now part of Takeda), Acorda Therapeutics
    Segments Covered End-User, Type of Treatment, Severity of Symptoms, Diagnostic Tools, Therapeutic Interventions, Regional
    Key Market Opportunities 1.       Increasing awareness of TS 2.       Growing prevalence of TS 3.       Rising demand for effective therapies 4.       Technological advancements in TS diagnosis and treatment 5.       Government initiatives to support TS research
    Key Market Dynamics 1.       Rising prevalence of Tourette syndrome 2.       Increasing awareness of the condition 3.       Growing demand for novel therapies 4.       Technological advancements in diagnosis and treatment 5.       Expanding market for personalized medicine
    Countries Covered North America, Europe, APAC, South America, MEA
    Market Size 2025 1.36 (USD Billion)

    FAQs

    What is the projected growth of the Tourette Syndrome market?

    The Tourette Syndrome market is the expected increase in total market value of 2.36 USD billion over a defined forecast period 2025–2035. It is driven by factors such as demand trends, technological advances, regulatory changes, and geographic expansion.

    What is the size of the Tourette Syndrome market?

    Tourette Syndrome market size was valued at approximately 1.29 billion USD in 2024. This figure will reach 2.36 billion USD covering all regions (America, Europe, Asia, MEA and ROW), focusing its segments / services / distribution channels till 2035.

    What is the CAGR of the Tourette Syndrome market?

    Tourette Syndrome market is expected to grow at a CAGR of 5.64% between 2025 and 2035.

    How much will the Tourette Syndrome market be worth by 2035?

    Tourette Syndrome market is expected to be worth of 2.36 billion USD, reflecting growth driven by usage, technology and global demands by the end of 2035.

    How will the Tourette Syndrome market perform over the next 10 years?

    Over the next 10 years the Tourette Syndrome market is expected to shift from usd billion 1.29 to 2.36 billion USD, led by adoption of advanced tech, demographic trends, regulatory approvals, with potential headwinds from 2025 to 2035.

    Which region is expected to dominate the Tourette Syndrome Market?

    North America is expected to dominate the Tourette Syndrome Market, accounting for a significant market share in 2024.

    What is the key application of the Tourette Syndrome Market?

    The key application of the Tourette Syndrome Market is in the treatment of tics and other symptoms associated with the disorder.

    Who are the key competitors in the Tourette Syndrome Market?

    Some of the key competitors in the Tourette Syndrome Market include Revance Therapeutics, Inc., Acadia Pharmaceuticals, Inc. and Neurocrine Biosciences, Inc.

    What are the factors driving the growth of the Tourette Syndrome Market?

    The increasing prevalence of Tourette syndrome and the growing awareness of treatment options are driving the growth of the Tourette Syndrome Market.

    What are the challenges faced by the Tourette Syndrome Market?

    The high cost of treatment and the lack of effective therapies are some of the challenges faced by the Tourette Syndrome Market.

    Download Free Sample

    Kindly complete the form below to receive a free sample of this Report

    Case Study
    Chemicals and Materials